Alex Zhavoronkov, Ph.D., Insilico Medicine, Inc

Alex Zhavoronkov, Ph.D. Dr. Zhavoronkov is the founder and CEO of Insilico Medicine, a Baltimore-based leader in the next-generation AI for drug discovery, biomarker development, and aging research. Prior to Insilico, he worked in senior roles at ATI Technologies, NeuroG Neuroinformatics, the Biogerontology Research Foundation and co-founded YLabs.AI. Since 2012 he published over 100 peer-reviewed research papers and two books. He organizes the annual Aging Forum and Artificial Intelligence for Healthcare Forum at EMBO/Basel Life in Basel. Dr. Zhavoronkov is an adjunct professor at the Buck Institute for Research on Aging.

Session

9:55 AM - 10:10 AM

Internal Collaboration: Moving Toward the Value of End-to-End Machine Learning for Pipeline Optimization


Download Latest Agenda